{
  "id": 9921515,
  "title": "Repligen CEO Loeillot sells $2.46m in shares",
  "url": "https://urgent.news/2026/09/26/repligen-ceo-loeillot-sells-2-46m-in-shares",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-26T06:02:19.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/repligen-ceo-loeillot-sells-246m-in-shares-93CH-4918475"
  },
  "original_language": "en",
  "account": "On September 24, 2026, Repligen Corp.'s CEO, Olivier Loeillot, sold approximately $2.46 million worth of the company's common stock, totaling 12,946 shares. This sale was executed under a Rule 10b5-1 trading plan, with each share priced at $190.00. The transactions occurred as RGEN shares were near their 52-week high of $192.49, following a 51% return over the past year. However, the stock was deemed overvalued by InvestingPro, trading at a P/E ratio of 260. Simultaneously, Loeillot acquired 12,946 shares through stock options, purchasing 8,404 shares at $154.96 and 4,542 shares at $155.38, amounting to a total value of $2.01 million. After these transactions, he directly holds 48,369 shares of Repligen common stock. The Form 4 filing detailing the ownership changes was signed by Jennifer Carmichael as Attorney in Fact on September 25, 2026. Recently, Repligen reported its second-quarter 2026 earnings, surpassing analyst expectations with adjusted earnings of $0.54 per share, exceeding the forecasted $0.45 per share. Revenue for the quarter was $204 million, slightly above the anticipated $201.47 million, indicating modest revenue growth. The company also raised its full-year outlook, signaling a positive trajectory. Canaccord Genuity maintained a Hold rating on Repligen with a price target of $145. These developments highlight Repligen's ability to outperform earnings estimates and provide an optimistic outlook for the remainder of the year.",
  "summary": null,
  "key_points": [
    "CEO Olivier Loeillot sold $2.46m in Repligen shares on September 24, 2026",
    "Transactions executed under Rule 10b5-1 plan at $190 per share",
    "Loeillot also bought 12,946 shares via stock options totaling $2.01m"
  ],
  "editors_take": "The CEO's simultaneous sale and purchase of shares suggest a strategic portfolio adjustment rather than a change in confidence in the company's prospects, which remain positive according to recent earnings and outlook.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}